ImmunityBio, Inc.
Nasdaq IBRX · San Diego, CA
Works in Dermatology · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health
ImmunityBio, Inc. is a clinical trial sponsor based in San Diego, CA, listed as Nasdaq IBRX. It has 22 active clinical trials with 1,944 planned participants, across 11 therapeutic areas. Since 2021 it has completed 18 trials and stopped 41 early. Its FDA record on file shows 1 warning letter.
Trial track record · since 2021
FDA record
Recent FDA actions
Financials · Nasdaq IBRX
Fundraising
Pipeline · 22 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about ImmunityBio, Inc
Yes. FDA has published 1 warning letter naming ImmunityBio, Inc; the latest was posted on 2026-03-24. Each letter links to FDA's own posting.
ImmunityBio, Inc is lead sponsor of 22 active clinical trials on ClinicalTrials.gov, with 1,944 planned participants, in Dermatology, GI & liver, Hematology, Immunology and other areas. Since 2021 it has completed 18 trials and stopped 41 early.
ImmunityBio, Inc is based in San Diego, CA and is listed as Nasdaq IBRX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with ImmunityBio, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-25.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with ImmunityBio, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.